EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
3.1.1.25 | (1R,5S)-oxabicyclooctenone + H2O |
- |
Homo sapiens |
? |
- |
? |
3.1.1.25 | (1R,5S)-oxabicyclooctenone + H2O |
enzyme variant Q192: 0.82% of the activity with phenyl acetate (cf. EC 3.1.1.2), enzyme variant R192: 0.75% of the activity with phenyl acetate (cf. EC 3.1.1.2) |
Homo sapiens |
? |
- |
? |
3.1.1.25 | (1S,5R)-oxabicyclooctenone + H2O |
- |
Homo sapiens |
? |
- |
? |
3.1.1.25 | (1S,5R)-oxabicyclooctenone + H2O |
enzyme variant Q192: 1.67% of the activity with phenyl acetate (cf. EC 3.1.1.2), enzyme variant R192: 2.92% of the activity with phenyl acetate (cf. EC 3.1.1.2) |
Homo sapiens |
? |
- |
? |
3.1.1.25 | (2S,4RS)-2-hydroxy-4-butyrolactone + H2O |
- |
Fusarium proliferatum |
(S)-2-hydroxy-4-phenylbutyrate |
- |
? |
3.1.1.25 | (R)-alpha-hydroxy-gamma-butyrolactone + H2O |
enzyme variant Q192: 0.88% of the activity with phenyl acetate (cf. EC 3.1.1.2), enzyme variant R192: 3.95% of the activity with phenyl acetate (cf. EC 3.1.1.2) |
Homo sapiens |
(R)-2-hydroxybutyric acid |
- |
? |
3.1.1.25 | (R)-dihydro-5-(hydroxymethyl)-2(3H)-furanone + H2O |
enzyme variant Q192: 1.23% of the activity with phenyl acetate (cf. EC 3.1.1.2), enzyme variant R192: 3.29% of the activity with phenyl acetate (cf. EC 3.1.1.2) |
Homo sapiens |
? |
- |
? |
3.1.1.25 | (R)-gamma-valerolactone + H2O |
- |
Homo sapiens |
4-hydroxypentanoic acid |
- |
? |
3.1.1.25 | (S)-alpha-hydroxy-gamma-butyrolactone + H2O |
enzyme variant Q192: 8.14% of the activity with phenyl acetate (cf. EC 3.1.1.2), enzyme variant R192: 19.6% of the activity with phenyl acetate (cf. EC 3.1.1.2) |
Homo sapiens |
(S)-2-hydroxybutyric acid |
- |
? |
3.1.1.25 | (S)-beta-hydroxy-gamma-butyrolactone + H2O |
enzyme variant Q192: 0.6% of the activity with phenyl acetate (cf. EC 3.1.1.2), enzyme variant R192: 0.76% of the activity with phenyl acetate (cf. EC 3.1.1.2) |
Homo sapiens |
(S)-3-hydroxybutyric acid |
- |
? |